logo

For the Inventor, By the Inventor

Jerusalem, Israel

Gamida Cell Ltd.


USPTO Granted Patents = 20

% Expired Patents = 45.0



Forward Citations = 146

Loading Chart...
Loading Chart...

11 inventors (with patents filed for the assignee):

goldMedal Tony Peled (20 out of 22 patents)

silverMedal Avi Treves (10 out of 10 patents)

bronzeMedal Eitan Fibach (7 out of 9 patents)

4.  Oren Rosen (3 out of 3 patents)

5.  Yair Steinhardt (2 out of 2 patents)

6.  Arik Hasson (1 out of 3 patents)

7.  Gabi M Frei (1 out of 1 patent)

8.  Efrat Landau (1 out of 1 patent)

9.  Dorit Harati (1 out of 1 patent)

10.  David Snyder (1 out of 1 patent)

11.  Einat Galamidi Cohen (1 out of 1 patent)

12.  Mark M Friedman (0 patent)


20 patents:

1. 11834677 - Expansion and use of expanded NK cell fractions (2023-12-05),
2. 11746325 - Selection and use of umbilical cord cell fractions suitable for transplantation (2023-09-05),
3. 11730771 - Selection and use of umbilical cord cell fractions suitable for transplantation (2023-08-22),
4. 10047345 - Culturing of mesenchymal stem cells with FGF4 and nicotinamide (2018-08-14),
5. 9567569 - Methods of culturing and expanding mesenchymal stem cells (2017-02-14),
6. 9175266 - Enhancement of natural killer (NK) cell proliferation and activity (2015-11-03),
7. 8986992 - Expansion of stem/progenitor cells by inhibition of enzymatic reactions catalyzed by the Sir2 family of enzymes (2015-03-24),
8. 8846393 - Methods of improving stem cell homing and engraftment (2014-09-30),
9. 8202724 - Methods of controlling proliferation and differentiation of stem and progenitor cells (2012-06-19),
10. 8187876 - Expansion of stem/progenitor cells by inhibition of enzymatic reactions catalyzed by the Sir2 family of enzymes (2012-05-29),
11. 8080417 - Methods of ex vivo hematopoietic stem cell expansion by co-culture with mesenchymal cells (2011-12-20),
12. 7955852 - Expansion of renewable stem cell populations (2011-06-07),
13. 7855075 - Methods of controlling proliferation and differentiation of stem and progenitor cells (2010-12-21),
14. 7655225 - Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby (2010-02-02),
15. 7429489 - Methods of controlling proliferation and differentiation of stem and progenitor cells (2008-09-30),
Company Overview
Gamida Cell Ltd. is a biotechnology company based in Jerusalem, specializing in cell therapy solutions for patients with cancer and other serious diseases. The organization focuses on developing innovative treatments that harness the power of the immune system, particularly through the use of advanced cell expansion technologies. Gamida Cell is dedicated to improving patient outcomes by providing novel therapeutic options that address unmet medical needs, positioning itself as a leader in the field of regenerative medicine.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

Gamida Cell Ltd. USPTO Patent Assignee Logo
20 Patents

#12 in Jerusalem

#306 in Israel

#31,264 in the World

Jerusalem, IL
Jerusalem, Israel

Gamida Cell Ltd.

Forward Citations = 146

11 inventors:

goldMedal Tony Peled (20 out of 22 patents)

silverMedal Avi Treves (10 out of 10 patents)

bronzeMedal Eitan Fibach (7 out of 9 patents)

4.  Oren Rosen (3 out of 3 patents)

5.  Yair Steinhardt (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Gamida Cell Ltd.. Retrieved from https://idiyas.com/company/gamida-cell

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…